[Pharmacological and clinical profile of dexrazoxane (SAVENE® Intravenous Infusion 500 mg), a therapeutic agent for anthracycline extravasation].
Kazuyasu
K
Maruyama
Naomi
N
Koshihara
D000818:Animals; D018943:Anthracyclines / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D064730:Dexrazoxane / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D007262:Infusions, Intravenous; D009369:Neoplasms / Q000188:drug therapy*; D012883:Skin Ulcer / Q000517:prevention & control
D018943:Anthracyclines; D064730:Dexrazoxane